Bain Capital Life Sciences Investors, LLC is an institution, managing $1.5B across 20 long positions as of Q3 2025 with 69% Healthcare concentration, 93% concentrated in top 10 holdings, and 28% allocation to HTFL.
Largest long holdings in Bain Capital Life Sciences Investors, LLC's portfolio (92.8% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Unknown Unknown | $419.0M | 27.84% | +$419.0M New | 14.93% 12.4M shares | |
Biotechnology Healthcare | $304.9M | 20.26% | — | 9.52% 10.7M shares | |
Biotechnology Healthcare | $289.3M | 19.22% | +$49.8M Bought | 11.91% 3.0M shares | |
Biotechnology Healthcare | $79.4M | 5.27% | -$3.0M Sold | 4.95% 3.2M shares | |
Biotechnology Healthcare | $67.0M | 4.45% | — | 9.97% 6.8M shares | |
Biotechnology Healthcare | $62.8M | 4.18% | — | 10.18% 17.6M shares | |
Biotechnology Healthcare | $51.8M | 3.44% | -$45.9M Sold | 3.30% 1.3M shares | |
Biotechnology Healthcare | $48.8M | 3.24% | — | 10.16% 7.9M shares | |
Unknown Unknown | $45.9M | 3.05% | — | 4.53% 2.4M shares | |
Medical - Devices Healthcare | $28.2M | 1.87% | — | 19.08% 8.4M shares |
Portfolio insights and performance metrics for Bain Capital Life Sciences Investors, LLC
No concentration data available
We use cookies for analytics. See our Privacy and Cookie Policy.